基因组数据的整合使得选择性发现乳腺癌驱动因素成为可能
Félix Sanchez-Garcia1, Patricia Villagrasa2, Junji Matsui2
1Department of Biological Sciences and Department of Systems Biology, Columbia University, New York, NY 10027, USA; Department of Computer Science, Columbia University, New York, NY 10027, USA.
新的算法Helios通过整合基因组和RNAi查数据来识别癌症驱动基因. 它准确地确定了像RSF-1这样的关键基因,有助于治疗开发和了解癌症进展.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 生物信息学是一种生物信息学.
背景情况:
- 识别癌症驱动基因对于治疗开发至关重要.
- 大幅放大DNA区域通常含有多个基因,使驾驶员识别复杂化.
- 目前的方法在这些地区确定特定的驱动基因方面面临挑战.
研究的目的:
- 开发和验证Helios,一种用于识别癌症驱动基因的算法.
- 在大,反复放大的DNA区域内精确地确定驱动基因.
- 提高对乳腺癌遗传学的理解,并确定新的治疗点.
主要方法:
- 从初级瘤的基因组数据与功能性RNAi查数据的整合.
- 开发Helios算法来分析放大DNA区域.
- 候选驱动基因的体外验证和小鼠模型表征.
主要成果:
- 赫里奥斯在乳腺癌中确定了与已知的驱动因素高度丰富的候选驱动因素 (p < 10(-14).
- 在Helios发现的十大基因中,有九个是已确定的乳腺癌驱动因素.
- 实验室内验证证实,12种候选药物中的10种增强了对位独立的生长.
- 赫里奥斯识别的驱动器RSF-1在小鼠模型中显示瘤发生和转移的增加.
结论:
- 赫利奥斯是一种敏感和特定的算法,用于识别癌症驱动基因.
- 该方法为癌症生物学和治疗策略提供了强大的洞察力.
- RSF-1放大与预后不佳有关,并促进瘤进展和转移.
更多相关视频
06:52Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
相关概念视频
Pharmacogenomics: Identification of New Drug Targets
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
